LEADER 02303nam  2200553   450 
001 9910463974003321
005 20200520144314.0
010   $a3-8382-5761-8
035   $a(CKB)2670000000547969
035   $a(EBL)2056683
035   $a(OCoLC)910447170
035   $a(SSID)ssj0001183741
035   $a(PQKBManifestationID)12543453
035   $a(PQKBTitleCode)TC0001183741
035   $a(PQKBWorkID)11189595
035   $a(PQKB)11296181
035   $a(MiAaPQ)EBC2056683
035   $a(MiAaPQ)EBC5781785
035   $a(Au-PeEL)EBL5781785
035   $a(OCoLC)903975115
035   $a(EXLCZ)992670000000547969
100   $a20190620d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aUkraine-Crimea-Russia $etriangle of conflict /$fTaras Kuzio
210  1$aStuttgart, Germany :$cIbidem Verlag,$d2012.
215   $a1 online resource (259 p.)
225 1 $aSoviet and Post-Soviet Politics and Society,$x1614-3515 ;$v47
300   $aDescription based upon print version of record.
311   $a3-89821-761-2 
320   $aIncludes bibliographical references.
330   $aThe Crimea was the only region of Ukraine in the 1990s where separatism arose and inter-ethnic conflict potentially could have taken place between the Ukrainian central government, ethnic Russians in the Crimea, and Crimean Tatars. Such a conflict would have inevitably drawn in Russia and Turkey. Russia had large numbers of troops in the Crimea within the former Soviet Black Sea Fleet. Ukraine also was a nuclear military power until 1996. This book analyses two inter-related issues. Firstly, it answers the question why Ukraine-Crimea-Russia traditionally have been a triangle of conflict over a
410  0$aSoviet and post-Soviet politics and society ;$v47.
607   $aCrimea (Ukraine)$xEthnic relations
607   $aUkraine$xForeign relations$zRussia (Federation)
607   $aRussia (Federation)$xForeign relations$zUkraine
608   $aElectronic books.
676   $a947.71
700   $aKuzio$b Taras$0756517
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910463974003321
996   $aUkraine-Crimea-Russia$92481638
997   $aUNINA

LEADER 01698nam  2200349   450 
001 9910688456203321
005 20230630044620.0
035   $a(CKB)5400000000044771
035   $a(NjHacI)995400000000044771
035   $a(EXLCZ)995400000000044771
100   $a20230630d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAdvances in Precision Medicine Oncology /$fHilal Arnouk, Bassam Hassan, editor
210  1$aLondon :$cIntechOpen,$d2021.
215   $a1 online resource (260 pages)
311   $a1-83968-869-6 
330   $aRecent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects.
606   $aCancer$xTreatment
615  0$aCancer$xTreatment.
676   $a616.99406
702   $aHassan$b Bassam
702   $aArnouk$b Hilal
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688456203321
996   $aAdvances in Precision Medicine Oncology$92828415
997   $aUNINA